192 related articles for article (PubMed ID: 32561334)
1. Recommendations for vaccination in patients with multiple sclerosis who are eligible for immunosuppressive therapies: Spanish consensus statement.
Otero-Romero S; Rodríguez-García J; Vilella A; Ara JR; Brieva L; Calles C; Carmona O; Casanova V; Costa-Frossard L; Eichau S; García-Merino JA; Garcia-Vidal C; González-Platas M; Llaneza M; Martínez-Ginés M; Meca-Lallana JE; Prieto JM; Rodríguez-Antigüedad A; Tintoré M; Blanco Y; Moral E;
Neurologia (Engl Ed); 2021; 36(1):50-60. PubMed ID: 32561334
[TBL] [Abstract][Full Text] [Related]
2. Position statement on infection screening, prophylaxis, and vaccination of pediatric patients with rheumatic diseases and immunosuppressive therapies, part 3: precautions in situations of surgery, fever, and opportunistic infections.
Clemente D; Cuadros EN; Lovillo MC; Hernández JC; Martín SG; Silveira LF; Cruz MJL; Tagarro A; Rueda RMA; López López A; Aritziturri MS; Calvo C
Eur J Pediatr; 2024 Feb; 183(2):915-927. PubMed ID: 38047962
[TBL] [Abstract][Full Text] [Related]
3. Consensus statement of the Spanish Society of Neurology on the treatment of multiple sclerosis and holistic patient management in 2023.
Meca-Lallana JE; Martínez Yélamos S; Eichau S; Llaneza MÁ; Martín Martínez J; Peña Martínez J; Meca Lallana V; Alonso Torres AM; Moral Torres E; Río J; Calles C; Ares Luque A; Ramió-Torrentà L; Marzo Sola ME; Prieto JM; Martínez Ginés ML; Arroyo R; Otano Martínez MÁ; Brieva Ruiz L; Gómez Gutiérrez M; Rodríguez-Antigüedad Zarranz A; Sánchez-Seco VG; Costa-Frossard L; Hernández Pérez MÁ; Landete Pascual L; González Platas M; Oreja-Guevara C
Neurologia (Engl Ed); 2024 Mar; 39(2):196-208. PubMed ID: 38237804
[TBL] [Abstract][Full Text] [Related]
4. Position statement of the Spanish Society of Pediatric Rheumatology on infection screening, prophylaxis, and vaccination of pediatric patients with rheumatic diseases and immunosuppressive therapies: Part 1 (screening).
Cuadros EN; Calzada-Hernández J; Clemente D; Martín SG; Silveira LF; Lirola-Cruz MJ; Tagarro A; Lovillo MC; Rueda RMA; López AL; Aritziturri MS; Calvo C
Eur J Pediatr; 2022 Jun; 181(6):2343-2354. PubMed ID: 35258699
[TBL] [Abstract][Full Text] [Related]
5. Immunization and multiple sclerosis: Recommendations from the French Multiple Sclerosis Society.
Lebrun C; Vukusic S; ;
Rev Neurol (Paris); 2019 Jun; 175(6):341-357. PubMed ID: 31036391
[TBL] [Abstract][Full Text] [Related]
6. Vaccinations in patients with multiple sclerosis: A Delphi consensus statement.
Riva A; Barcella V; Benatti SV; Capobianco M; Capra R; Cinque P; Comi G; Fasolo MM; Franzetti F; Galli M; Gerevini S; Meroni L; Origoni M; Prosperini L; Puoti M; Scarpazza C; Tortorella C; Zaffaroni M; Moiola L
Mult Scler; 2021 Mar; 27(3):347-359. PubMed ID: 32940128
[TBL] [Abstract][Full Text] [Related]
7. Consensus document of the Spanish Society of Paediatric Infectious Diseases and the Advisory Committee on Vaccines of the Spanish Association of Pediatrics for vaccination of immunosuppressed individuals.
Rivero Calle I; Del Rosal Rabes T; Garrote Llanos E; Núñez Cuadros E; Navarro Gómez ML; Ramos Amador JT; Calvo C; Álvarez García F;
An Pediatr (Engl Ed); 2023 Dec; 99(6):403-421. PubMed ID: 38057232
[TBL] [Abstract][Full Text] [Related]
8. Infections and multiple sclerosis: Recommendations from the French Multiple Sclerosis Society.
Papeix C; Donze C; Lebrun-Frénay C; ; ; ; ; ;
Rev Neurol (Paris); 2021 Oct; 177(8):980-994. PubMed ID: 34303537
[TBL] [Abstract][Full Text] [Related]
9. Immunization and multiple sclerosis: Recommendations from the French multiple sclerosis society.
Lebrun C; Vukusic S;
Mult Scler Relat Disord; 2019 Jun; 31():173-188. PubMed ID: 31159998
[TBL] [Abstract][Full Text] [Related]
10. Consensus statement on the treatment of multiple sclerosis by the Spanish Society of Neurology in 2016.
García Merino A; Ramón Ara Callizo J; Fernández Fernández O; Landete Pascual L; Moral Torres E; Rodríguez-Antigüedad Zarrantz A
Neurologia; 2017 Mar; 32(2):113-119. PubMed ID: 27157522
[TBL] [Abstract][Full Text] [Related]
11. ECTRIMS/EAN consensus on vaccination in people with multiple sclerosis: Improving immunization strategies in the era of highly active immunotherapeutic drugs.
Otero-Romero S; Lebrun-Frénay C; Reyes S; Amato MP; Campins M; Farez M; Filippi M; Hacohen Y; Hemmer B; Juuti R; Magyari M; Oreja-Guevara C; Siva A; Vukusic S; Tintoré M
Mult Scler; 2023 Jul; 29(8):904-925. PubMed ID: 37293841
[TBL] [Abstract][Full Text] [Related]
12. European Committee for Treatment and Research in Multiple Sclerosis and European Academy of Neurology consensus on vaccination in people with multiple sclerosis: Improving immunization strategies in the era of highly active immunotherapeutic drugs.
Otero-Romero S; Lebrun-Frénay C; Reyes S; Amato MP; Campins M; Farez M; Filippi M; Hacohen Y; Hemmer B; Juuti R; Magyari M; Oreja-Guevara C; Siva A; Vukusic S; Tintoré M
Eur J Neurol; 2023 Aug; 30(8):2144-2176. PubMed ID: 37293849
[TBL] [Abstract][Full Text] [Related]
13. Vaccination in Multiple Sclerosis: Friend or Foe?
Zrzavy T; Kollaritsch H; Rommer PS; Boxberger N; Loebermann M; Wimmer I; Winkelmann A; Zettl UK
Front Immunol; 2019; 10():1883. PubMed ID: 31440255
[TBL] [Abstract][Full Text] [Related]
14. [Vaccination].
Graubner UB; Liese J; Belohradsky BH
Klin Padiatr; 2001 Sep; 213 Suppl 1():A77-83. PubMed ID: 11577366
[TBL] [Abstract][Full Text] [Related]
15. Position statement on infection screening, prophylaxis, and vaccination in pediatric patients with rheumatic diseases and immunosuppressive therapies, part 2: infection prophylaxis.
Clemente Garulo D; Núñez-Cuadros E; Camacho Lovillo M; Calzada-Hernández J; Guillén Martín S; Fernández Silveira L; Lirola Cruz MJ; Tagarro A; Alcobendas Rueda RM; López López A; Satrustegi Aritziturri M; Calvo C
Eur J Pediatr; 2023 Sep; 182(9):4271-4284. PubMed ID: 37439850
[TBL] [Abstract][Full Text] [Related]
16. The risk of infection in patients with multiple sclerosis treated with disease-modifying therapies: A Delphi consensus statement.
Moiola L; Barcella V; Benatti S; Capobianco M; Capra R; Cinque P; Comi G; Fasolo MM; Franzetti F; Galli M; Gerevini S; Meroni L; Origoni M; Prosperini L; Puoti M; Scarpazza C; Tortorella C; Zaffaroni M; Riva A
Mult Scler; 2021 Mar; 27(3):331-346. PubMed ID: 32940121
[TBL] [Abstract][Full Text] [Related]
17. Vaccination recommendations for the adult immunosuppressed patient: A systematic review and comprehensive field synopsis.
Lopez A; Mariette X; Bachelez H; Belot A; Bonnotte B; Hachulla E; Lahfa M; Lortholary O; Loulergue P; Paul S; Roblin X; Sibilia J; Blum M; Danese S; Bonovas S; Peyrin-Biroulet L
J Autoimmun; 2017 Jun; 80():10-27. PubMed ID: 28381345
[TBL] [Abstract][Full Text] [Related]
18. Vaccinations in children on immunosuppressive medications for renal disease.
Banerjee S; Dissanayake PV; Abeyagunawardena AS
Pediatr Nephrol; 2016 Sep; 31(9):1437-48. PubMed ID: 26450774
[TBL] [Abstract][Full Text] [Related]
19. [Guidelines for vaccination of immunocompromised individuals].
Wiedermann U; Sitte HH; Burgmann H; Eser A; Falb P; Holzmann H; Kitchen M; Köller M; Kollaritsch H; Kundi M; Lassmann H; Mutz I; Pickl WF; Riedl E; Sibilia M; Thalhammer F; Tucek B; Zenz W; Zwiauer K
Wien Klin Wochenschr; 2016 Aug; 128 Suppl 4():337-76. PubMed ID: 27457874
[TBL] [Abstract][Full Text] [Related]
20. Vaccines: Considerations for pediatric dermatology patients on immunosuppressive agents.
Munshi MA; Noe MH; Chiu YE; Streicher JL
Pediatr Dermatol; 2021 Sep; 38(5):1040-1046. PubMed ID: 34060143
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
